This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Scotts Miracle-Gro (SMG) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Scotts (SMG) delivered earnings and revenue surprises of -11.94% and -1.98%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Scotts Miracle-Gro (SMG) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Scotts (SMG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Under-The-Radar Marijuana Stocks & News from GM, LEN, AMD | Free Lunch
by Ryan McQueeney
Ryan McQueeney discusses the Dow's record open and Jerome Powell's latest comments on the economy. He also recaps trending stories like the GM-Honda autonomous partnership, Lennar's earnings, and AMD's recent volatility. Later, Ryan highlights two under-the-radar marijuana stocks.
Fertilizers Industry Outlook: Near-Term Prospects Cloudy
by Zacks Equity Research
While the fertilizers makers are witnessing an improving nutrient demand and pricing environment, weak agricultural commodity prices and escalating trade tensions may weigh on the industry.
Nova Measuring, Scotts Miracle, PayPal and eBay highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Nova Measuring, Scotts Miracle, PayPal and eBay highlighted as Zacks Bull and Bear of the Day
Bear Of The Day: Scotts Miracle-Gro (SMG)
by Brian Bolan
Consistently lower earnings estimates have helped keep this stock a Zacks Rank #5 (Strong Sell) for months, but I still keep it on my radar screen.
What Investors Need to Know About Investing In Marijuana Stocks
by Benjamin Rains
Marijuana has come a long way since California legalized cannabis for medicinal use back in 1996. Today, the industry and marijuana look to be on the cusp of unprecedented acceptance, with major international giants investing billions into publicly traded cannabis companies. So let's take a look at what investors need to know about the marijuana industry and how to invest in the future of pot.
CRON, CGC Sink Ahead of Earnings: What To Watch From These Pot Stocks
by Benjamin Rains
Recreational marijuana is now legal in Canada as well as a number of states in the U.S. Companies have raced to get in on the multibillion-dollar a year industry, so let's see how two of the bigger pure-play pot stocks, Cronos Group (CRON) and Canopy Growth (CGC), are projected to perform Tuesday.
Where to Find the Best Marijuana Stocks
by Tracey Ryniec
The marijuana industry continues to grow and so do the investing opportunities. Where can you find them now?
Where to Find the Best Marijuana Stocks
by Tracey Ryniec
The marijuana industry continues to grow and so do the investing opportunities. Where can you find them now?
Scotts Miracle-Gro (SMG) Q3 Earnings Top, Sales Lag Estimates
by Zacks Equity Research
Scotts Miracle-Gro (SMG) reiterates its adjusted earnings outlook for fiscal 2018 in the range of $3.70-$3.90 per share.
5 Must-See Earnings Charts
by Tracey Ryniec
Interested in marijuana, fertilizers and furniture? Companies involved in those industries will be reporting this weekk
Scotts Miracle-Gro (SMG) Provides Update on FY18 Outlook
by Zacks Equity Research
For fiscal 2018, Scotts Miracle-Gro (SMG) expects adjusted earnings in the range of $3.70-$3.90 per share, including dilution associated with the Sunlight transaction.
Trade Desk, Scotts Miracle-Gro and Cisco Systems highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Trade Desk, Scotts Miracle-Gro and Cisco Systems highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Scotts Miracle-Gro (SMG)
by Madeleine Johnson
After disappointing earnings, can a budding marijuana business boost this lawncare stock?
Zacks Market Edge Highlights: Scotts Miracle-Gro, GW Pharmaceuticals, Innovative Industrial Properties and AbbVie
by Zacks Equity Research
Zacks Market Edge Highlights: Scotts Miracle-Gro, GW Pharmaceuticals, Innovative Industrial Properties and AbbVie
The Best Marijuana Stocks Right Now
by Tracey Ryniec
It is getting easier to buy stocks that do business in the emerging cannibis industry. Tracey and Dave explore all the options.
Company News For Jan 31, 2018
by Zacks Equity Research
Companies In The News are: AET,MXIM,AXE,SMG
Bear Of The Day: Scotts Miracle-Gro (SMG)
by Brian Bolan
A Zacks Rank #5 (Strong Sell) and some really bad style scores means this stock is thick in the weeds.
5 GARP Stocks for a Winning Portfolio
by Zacks Equity Research
The GARP strategy seeks to offer an ideal investment by utilizing the best features of both value and growth investing.
Goldcorp (GG) Q4 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
Goldcorp Inc. (GG) reported net earnings of $101 million or 12 cents per share for fourth-quarter 2016 which beat the Zacks Consensus Estimate of 9 cents.
CVR Partners (UAN) Records Q4 Loss, Revenues Beat Estimates
by Zacks Equity Research
CVR Partners (UAN) swung to a loss in the fourth quarter of 2016 while its sales beat estimates.
Top Ranked Momentum Stocks to Buy for February 13th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 13th:
Top Ranked Growth Stocks to Buy for January 26th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 26th:
4 Best Marijuana Stocks to Play the Green Rush
by Zacks Equity Research
Not only is marijuana one of the fastest growing industries in the U.S., but it also received a major boost after the 2016 election. Find out which stocks you should play the green rush with.